ANIEMEA-P-GB-202502918 (v2) | February 2026
Publish Date:
March 2023 | 2 min
Abstract:
This article discusses the impact of muscle loss to both adult patients and the NHS. Early diagnosis and intervention are fundamental in trying to reduce the impact of this on clinical outcomes as well as NHS costs. One of the interventions discussed in more detail in this article is the management of patients with or at risk of muscle loss and/or malnutrition with oral nutritional supplements containing β-hydroxy-β-methylbutyrate (HMB).
Once you have read this article, please remember to complete your self-reflective notes to contribute towards your continuing professional development. You will then be able to access your Certificate of Completion.
LEARNING OBJECTIVES
Understand the burden of loss of muscle mass and strength (sarcopenia) on older patients and the healthcare service.
Identify the importance of early screening and intervention for those at risk.
Explain the benefits of maintaining muscle mass through the use of oral nutritional supplements containing HMB.
